Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,381,520
+$323,195 QoQ
Shares Held
9,464
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#1,830
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DELTA FINANCIAL ADVISORS LLC holds $17,401,793 across 7 Drug Manufacturers - General names. ABBV ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,593 | $6,499,854 | |
| 2 | AMGN |
Amgen Inc
|
10,233 | $3,705,573 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
9,464 | $2,381,520 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,179 | $2,079,001 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,459 | $1,524,567 | |
| 6 | PFE |
Pfizer Inc
|
25,454 | $612,932 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,736 | $598,346 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,381,520 | 9,464 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,058,325 | 9,464 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,162,429 | 9,464 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,614,065 | 6,971 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $397,412 | 2,141 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $466,601 | 2,227 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $395,737 | 2,227 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $439,787 | 2,227 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $388,492 | 2,265 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $412,456 | 2,265 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $340,469 | 2,197 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $409,467 | 2,747 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $376,435 | 2,794 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $361,610 | 2,269 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $366,693 | 2,269 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $304,522 | 2,269 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $292,076 | 1,907 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $309,143 | 1,907 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $258,207 | 1,907 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $210,777 | 1,954 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $220,098 | 1,954 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $220,660 | 2,039 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $218,478 | 2,039 | Shares | Sole | 2021-01-28 | |
| No filing history on record for this holder in this stock. | ||||||